Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Thoracic Committee
Director: Professor David Plachard
Coordinated Expertise in Thoracic Cancers
The committee is composed of experts from the International Center for Thoracic Cancers. It brings together medical oncologists, pulmonologists, thoracic and cardiovascular surgeons, radiation oncologists, radiologists, interventional radiologists, nuclear medicine physicians, and pathologists to provide coordinated care for thoracic cancers. The committee organizes multidisciplinary team (MDT) meetings, during which the medical records of cancer patients are reviewed and discussed collectively to determine the treatment strategy best suited to the type of tumor, its stage, and each patient’s individual circumstances.
The committee’s physicians also contribute to the advancement of clinical and translational research in thoracic oncology and participate in numerous clinical trials aimed at improving diagnosis, treatment, and quality of life for patients with thoracic cancers.
The International Center for Thoracic Cancers
- Gustave Roussy in cancer care and radiation therapy.
- Marie-Lannelongue Hospital for surgical care.
- Paris Saint-Joseph Hospital, for comprehensive pulmonology and thoracic oncology care.
→ Learn more about the International Center for Thoracic Cancers
Types of Cancer Treated
- Bronchopulmonary Cancers in Adults:
Non-Small-Cell Carcinomas and Small-Cell Carcinomas - Pleural tumors
Mesotheliomas - Mediastinal tumors
- Pleuropulmonary metastases
Pleuropulmonary metastases from other primary cancers - Cancers of the pleura
- Thymomas
Specific Areas of Expertise
Gustave Roussy is the coordinator of RYTHMIC, the national network dedicated to thymic tumors
Stereotactic Radiotherapy
Intensity-Modulated Radiotherapy and Image-Guided Radiotherapy
Tomotherapy
Access to clinical trials and innovations in targeted therapies, immunotherapy, and precision radiation therapy
The Committee's Professionals
Committee Chair:
Dr. David Planchard, Medical Oncologist
Radiation Oncology:
Dr. Angela Botticella
Dr. Cécile Le Péchoux
Dr. Antonin Levy
Radiology
Dr. Ines Kasraoui
Interventional Radiology:
Dr. Paul Beunon
Prof. Lambros Tselikas
Medical Oncology:
Dr. Mihaela Aldea
Prof. Fabrice Barlesi
Prof. Benjamin Besse
Dr. Pernelle Lavaud
Dr. Pamella Abdayem
Dr. Maxime Frelaud
Dr. Adrien Rousseau
Immuno-Oncology
Prof. Aurélien Marabelle
Nuclear Medicine
Dr. Camilo Garzia
Pulmonology
Dr. Adrian Crutu
Dr. Gaëlle Dauriat
Dr. Séverine Feuillet
Dr. Amir Hanna
Prof. Jérôme Le Pavec
Dr. Pauline Pradere
Pathology
Dr. Vincent Thomas de Montpreville
Thoracic and Cardiovascular Surgery
Prof. Dominique Fabre
Prof. Elie Fadel
Dr. Antoine Girault
Dr. Jean-Baptiste Menager
Prof. Olaf Mercier
Dr. Delphine Mitilian
Dr. Sacha Mussot
Radiology
Dr. Caroline Caramella
Medical Oncology
Dr. Charles Naltet
Thoracic Oncology:
Dr. Flore Bintein
Dr. Marie de Torcy
Dr. Stéphane Jouveshomme
Interventional Radiology:
Dr. Caroline Touloupas
Pathology:
Prof. Julien Adam
Radiology:
Dr. Valéria Marini
Translational Research on Thoracic Tumors
The committee works closely with the Institute’s research teams and units:
• The Molecular Radiotherapy and Therapeutic Innovations Research Unit (U1355 RAMO-IT)
• The Rare Circulating Cells Platform, led by Marianne Oulhen
• The Tumor Plasticity under Anticancer Therapy team, led by Luc Friboulet, affiliated with U981 Molecular Predictors and New Targets in Oncology.
Rare Circulating Cells Platform
The platform specializes in the molecular analysis of rare blood cell components, such as circulating tumor cells and circulating endothelial cells or progenitors, which are used as biomarkers in therapeutic trials.